Stay updated on Magrolimab in Hematological Malignancies Clinical Trial
Sign up to get notified when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.

Latest updates to the Magrolimab in Hematological Malignancies Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page’s footer revision label was updated from **v3.5.0** to **v3.5.3**, indicating a site release/version change without altering the clinical trial’s study details.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check44 days agoChange DetectedThe page revision label updates to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision: v3.4.3 replaces v3.4.2 on the page.SummaryDifference0.0%

- Check80 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1. The new screenshot shows the updated version label with no visible changes to study content.SummaryDifference0.0%

- Check88 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1, a minor metadata change with no impact on page content or usability. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check110 days agoChange DetectedAdded Revision: v3.3.4 and removed Revision: v3.3.3 from the page metadata.SummaryDifference0.0%

Stay in the know with updates to Magrolimab in Hematological Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Magrolimab in Hematological Malignancies Clinical Trial page.